Because of an error in the Neurology editorial office's content management system, several papers were published without their preprint server information. The preprint information, which should have been listed in the Publication History section, is provided for each paper below.
“Association Between Diseases and Symptoms Diagnosed in Primary Care and the Subsequent Specific Risk of Multiple Sclerosis” by Guinebretiere et al.1: Previously published in MedRxiv (doi.org/10.1101/2022.11.16.22282386).
“Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease: A Potential Diagnostic Approach” by Acha et al.2: Previously published in Research Square (doi.org/10.21203/rs.3.rs-2385191/v1).
“Association of Poor Oral Health With Neuroimaging Markers of White Matter Injury in Middle-Aged Participants in the UK Biobank” by Rivier et al.3: Previously published in MedRxiv (doi.org/10.1101/2023.03.18.23287435).
“Association of PM2.5 Exposure and Alzheimer Disease Pathology in Brain Bank Donors—Effect Modification by APOE Genotype” by Christensen et al.4: Previously published in MedRxiv (doi.org/10.1101/2023.04.07.23288288).
“Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study” by Spelman et al.5: Previously published in MedRxiv (doi.org/10.1101/2022.10.12.22280969).
“Evaluation of ATNPD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease” by Cousins et al.6: Previously published in MedRxiv (doi.org/10.1101/2023.04.21.23288930v1).
“Interplay Between Chronic Kidney Disease, Hypertension, and Stroke: Insights From a Multivariable Mendelian Randomization Analysis” by Kelly et al.7: Previously published in MedRxiv (doi.org/10.1101/2022.09.14.22279923).
“Single Nucleotide Polymorphisms Associated With Motor Recovery in Patients With Nondisabling Stroke:GWAS Study” by Aldridge et al.8: Previously published in MedRxiv (doi.org/10.1101/2023.02.16.23286040).
“Trends in Cognitive Function Before and After Diabetes Onset: The China Health and Retirement Longitudinal Study” by Chen et al.9: Previously published in MedRxiv (doi.org/10.1101/2023.07.02.23292154).
The editorial office regrets the omissions.
References
- 1.Guinebretiere O, Nedelec T, Gantzer L, Lekens B, Durrleman S, Louapre C. Association between diseases and symptoms diagnosed in primary care and the subsequent specific risk of multiple sclerosis. Neurology. 2023;101(24):e2497-e2508. doi: 10.1212/WNL.0000000000207981 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Acha B, Corroza J, Sánchez-Ruiz de Gordoa J, et al. . Association of blood-based DNA methylation markers with late-onset Alzheimer disease: a potential diagnostic approach. Neurology. 2023;101(23):e2434-e2447. doi: 10.1212/WNL.0000000000207865 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Rivier CA, Renedo DB, de Havenon A, et al. . Association of poor oral health with neuroimaging markers of white matter injury in middle-aged participants in the UK biobank. Neurology. 2024;102(2):e208010. doi: 10.1212/WNL.0000000000208010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Christensen GM, Li Z, Liang D, et al. . Association of PM2.5 exposure and Alzheimer disease pathology in brain bank donors—effect modification by APOE genotype. Neurology. 2024;102(5):e209162. doi: 10.1212/WNL.0000000000209162 [DOI] [PubMed] [Google Scholar]
- 5.Spelman T, Simoneau G, Hyde R, et al. . Comparative effectiveness of natalizumab, fingolimod, and injectable therapies in pediatric-onset multiple sclerosis: a registry-based study. Neruology 2024;102(7):e208114. doi: 10.1212/WNL.0000000000208114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Cousins KAQ, Irwin DJ, Tropea TF, et al. . Evaluation of ATNPD framework and biofluid markers to predict cognitive decline in early Parkinson disease. Neurology. 2024;102(4):e208033. doi: 10.1212/WNL.0000000000208033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kelly DM, Georgakis MK, Franceschini N, et al. . Interplay between chronic kidney disease, hypertension, and stroke: insights from a multivariable mendelian randomization analysis. Neurology. 2023;101(20):e1960-e1969. doi: 10.1212/WNL.0000000000207852 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Aldridge CM, Braun R, Keene KL, Hsu F-C, Worrall BB. Single nucleotide polymorphisms associated with motor recovery in patients with nondisabling stroke: GWAS study. Neurology. 2023;101(21):e2114-e2125. doi: 10.1212/WNL.0000000000207716 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Chen Q, Zhu S, Shang J, Fang Q, Xue Q, Hua J. Trends in cognitive function before and after. Neurology. 2024;102(7):e209165. doi: 10.1212/WNL.0000000000209165 [DOI] [PubMed] [Google Scholar]